BSECompany Update11 Aug 2026 · 11 Aug 2026, 06:03 pm
Press Release regarding Financial Results of the Company for the quarter ended June 30, 2026, along with the declaration of dividend at the rate of 10% i.e. Rs. 1/- per Equity Share.
Prevest Denpro Ltd · 543363
✦ AI Summary▲ PositiveResults
Prevest Denpro Ltd reported strong Q1 FY 2026-27 performance with 20.94% YoY revenue growth and 27.99% YoY PAT rise. The company declared a 10% dividend at ₹1 per equity share.
Analysis Scores
Earnings Impact8/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact9/10
Market Sentiment9/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Prevest Denpro Ltd - 543363 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Attachments (1)
📄pdf
Download →
5a028935-ae2c-49f9-a732-17b7f90978a5.pdf
View document text
August 11, 2026
BSE Limited,
Corporate Relationship Department,
P.J. Towers, Dalal Street,
Mumbai 400 001
Scrip No. 543363
Sub: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015 (“Listing Regulations”)- Press Release.
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, please find enclosed herewith the Press Release regarding the Financial Results of the Company
for the quarter ended June 30, 2026, along with the declaration of dividend at the rate of 10%, i.e., ₹1/-
per equity share.
We request you to take the same on your record.
Thanking You,
Yours faithfully,
For Prevest Denpro Limited
Pratul Gupta
Company Secretary & Compliance Officer
Encl: As above
PRESS RELEASE
Prevest Denpro Limited Reports Strong Q1 FY 2026–27
Performance
Revenue from Operations grows 20.94% YoY and Consolidated PAT rises 27.99% YoY
Jammu, August 11, 2026 – Prevest Denpro Limited, a leading dental products company, today announced its financial results for
the quarter ended June 30, 2026. The Company delivered strong growth across key financial parameters, supported by continued
business momentum and sustained demand across its product portfolio.
Note: All financial figures are stated in ₹ Lakhs, unless otherwise indicated.
MANAGEMENT COMMENTARY
“We are pleased to begin FY 2026-27 on a strong note, delivering healthy double-digit growth across our key financial
parameters. Our consolidated Revenue from Operations grew 20.94% year-on-year, while EBITDA, PBT and PAT increased by
24.73%, 26.23% and 27.99%, respectively. The performance reflects the continued strength of our business fundamentals,
growing acceptance of our dental product portfolio and our focus on operational efficiency. We remain committed to
expanding our product offerings, strengthening our domestic and international presence and creating sustainable long-term
value for our stakeholders. We remain optimistic about the year ahead and focused on driving sustainable growth through
continued innovation, product development, operational excellence and expansion across domestic and international
markets.”
— Mr. Atul Modi, Chairman and Managing Director
KEY FINANCIAL HIGHLIGHTS
Standalone Results
● Revenue from Operations: grew 23.66% YoY to ₹1,944.33 lakh, compared to ₹1,572.27 lakh in Q1 FY 2025-26, and
increased 2.85% QoQ from ₹1,890.40 lakh
● Total Income: grew 22.96% YoY to ₹2,077.40 lakh, compared to ₹1,689.53 lakh in Q1 FY 2025-26, and increased 2.00% QoQ
from ₹2,036.66 lakh
● EBITDA: grew 22.60% YoY to ₹821.88 lakh, compared to ₹670.40 lakh in Q1 FY 2025-26
● PBT: grew 23.96% YoY to ₹770.26 lakh, compared to ₹621.38 lakh in Q1 FY 2025-26
● PAT: grew 24.77% YoY to ₹578.23 lakh, compared to ₹463.42 lakh in Q1 FY 2025-26
Consolidated Results
● Revenue from Operations: grew 20.94% YoY to ₹1,906.83 lakh, compared to ₹1,576.63 lakh in Q1 FY 2025-26, and
increased 0.67% QoQ from ₹1,894.06 lakh
● Total Income: grew 20.38% YoY to ₹2,038.36 lakh, compared to ₹1,693.24 lakh in Q1 FY 2025-26, and increased 0.18% QoQ
from ₹2,034.67 lakh
● EBITDA: grew 24.73% YoY to ₹808.14 lakh, compared to ₹647.93 lakh in Q1 FY 2025-26
● PBT: grew 26.23% YoY to ₹755.89 lakh, compared to ₹598.82 lakh in Q1 FY 2025-26
● PAT: grew 27.99% YoY to ₹563.86 lakh, compared to ₹440.54 lakh in Q1 FY 2025-26
DIVIDEND DECLARATION
● The Board of Directors has recommended a dividend of 10% (₹1 per equity share) for FY 2025-26, subject to shareholder
approval, as applicable.
ABOUT PREVEST DENPRO LIMITED
Prevest Denpro Limited is a leading manufacturer of dental materials and products, offering a comprehensive portfolio of dental
solutions across restorative dentistry, endodontics, adhesives and bonding agents, preventive care, prosthodontics and other
segments. With a focus on innovation, quality and product development, the Company serves dental professionals across
domestic and international markets.
Prevest Denpro Limited | Jammu, India
This press release is for informational purposes and contains forward-looking statements subject to risks and uncertainties.